| Jon Lyons |
Jon Lyons is currently the Vice President-Scientific & Medical Affairs at Biofrontera, Inc. He holds an MBA from the University of Memphis. |
| Fred Leffler |
Fred Leffler is currently working as a Senior Director-Corporate Finance & Restructuring at FTI Consulting, Inc. He also holds the position of Senior Manager at McKinsey & Co., Inc. and Chief Financial Officer at Biofrontera, Inc. He previously worked as Vice President-Data & Analytics at Rockcreek, Inc. and Senior Manager at McKinsey & Co., Inc. He holds an MBA degree from The Fuqua School of Business and an undergraduate degree from Fisher College of Business. |
| Daniel Hakansson |
Daniel Hakansson is currently the General Counsel & Head-Compliance at Biofrontera, Inc. He completed his undergraduate degree at the University of Massachusetts and his graduate degree at the University of New Hampshire School of Law. |
| Armin Ollig |
Presently, Armin Ollig holds the position of Vice President-Information Technology for Biofrontera, Inc. |
| Hermann Lübbert |
Hermann Lübbert was the founder and had founded Biofrontera AG in 1997, where he held the title of Chairman-Management Board & CEO until 2021. He currently holds the position of Chairman & Chief Executive Officer at Biofrontera, Inc. since 2015. He is also the Co-Managing Director at Biofrontera Bioscience GmbH and a Professor at Ruhr-Universität Bochum. In the past, he served as Co-Managing Director at Biofrontera Pharma GmbH and as a Member at Novartis Pharma AG. Dr. Lübbert obtained his doctorate degree from Universität zu Köln in 1984. |
| Kevin D. Weber |
Kevin D. Weber is an Independent Director at Biofrontera, Inc. and a Principal-Commercial Strategy at Skysis LLC. He previously worked as the Chief Executive Officer at PFN Liquidating Corp., Inc., Director at Arizona Bioindustry Association, Director at American Academy of Pain Medicine, Director at American Chronic Pain Association, Vice President-Marketing at Assertio Therapeutics, Inc., and Principal at VHA, Inc. He was also a Member-Supervisory Board at Biofrontera AG from 2016 to 2021. Mr. Weber received an undergraduate degree from Western Michigan University. |
| Beth J. Hoffman |
Beth J. Hoffman is the founder of Origami Therapeutics, Inc., where she holds the title of President & Chief Executive Officer since 2015. She is also currently working as an Independent Director at Biofrontera, Inc. since 2015. Dr. Hoffman obtained a doctorate degree from The Johns Hopkins University. |
| John J. Borer |
John J. Borer is an Independent Director at Biofrontera, Inc. He previously served as the Chief Executive Officer at Rodman & Renshaw Holding LLC and Enthrust Financial Services, Inc. He was also a Senior Managing Director at Rodman & Renshaw LLC (Old) and Director & Head-Investment Banking at Direct Markets Holdings Corp. Borer was a Member-Supervisory Board at Biofrontera AG. He worked as a Senior Vice President & Investment Manager at Security Pacific Business Credit, Inc. and as a Vice President & Business Development Officer at Barclays American Business Credit, Inc. Borer received his undergraduate degree from the University of California, Davis and his graduate degree from Loyola Law School. |
